Aniket V Gore1, Kelly A Tomins2, James Iben3, Li Ma4, Daniel Castranova2, Andrew E Davis2, Amy Parkhurst2, William R Jeffery4, Brant M Weinstein5. 1. Division of Developmental Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA. gore.aniket@nih.gov. 2. Division of Developmental Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA. 3. Molecular Genomics Laboratory, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA. 4. Department of Biology, University of Maryland, College Park, MD, USA. 5. Division of Developmental Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA. bw96w@nih.gov.
Abstract
Coding and non-coding mutations in DNA contribute significantly to phenotypic variability during evolution. However, less is known about the role of epigenetics in this process. Although previous studies have identified eye development genes associated with the loss-of-eyes phenotype in the Pachón blind cave morph of the Mexican tetra Astyanax mexicanus, no inactivating mutations have been found in any of these genes. Here, we show that excess DNA methylation-based epigenetic silencing promotes eye degeneration in blind cave A. mexicanus. By performing parallel analyses in A. mexicanus cave and surface morphs, and in the zebrafish Danio rerio, we have discovered that DNA methylation mediates eye-specific gene repression and globally regulates early eye development. The most significantly hypermethylated and downregulated genes in the cave morph are also linked to human eye disorders, suggesting that the function of these genes is conserved across vertebrates. Our results show that changes in DNA methylation-based gene repression can serve as an important molecular mechanism generating phenotypic diversity during development and evolution.
Coding and non-coding mutations in DNA contribute significantly to phenotypic variability during evolution. However, less is known about the role of epigenetics in this process. Although previous studies have identified eye development genes associated with the loss-of-eyes phenotype in the Pachón blind cave morph of the Mexican tetraAstyanax mexicanus, no inactivating mutations have been found in any of these genes. Here, we show that excess DNA methylation-based epigenetic silencing promotes eye degeneration in blind cave A. mexicanus. By performing parallel analyses in A. mexicanus cave and surface morphs, and in the zebrafishDanio rerio, we have discovered that DNA methylation mediates eye-specific gene repression and globally regulates early eye development. The most significantly hypermethylated and downregulated genes in the cave morph are also linked to humaneye disorders, suggesting that the function of these genes is conserved across vertebrates. Our results show that changes in DNA methylation-based gene repression can serve as an important molecular mechanism generating phenotypic diversity during development and evolution.
Subterranean animals offer an excellent opportunity to study morphological, molecular and physiological changes that allow organisms to adapt to unique environments. Loss of eyes is one of the most common morphological features of cave-adapted animals, including many fish species. Blind cave fish (CF) morphs of Astyanax mexicanus evolved from surface fish (SF) during a few million years of isolation in dark Mexican caves[1], with recent studies suggesting that regression of eyes evolved as part of a strategy to conserve energy in fish adapted to dark and nutrient deficient caves[2]. Although a number of studies have examined molecular mechanisms underlying eye loss in Pachón cave-derived Astyanax mexicanus CF, recent sequencing of the Pachón CF genome and other studies revealed no inactivating null mutations in essential eye development genes[3-7]. In contrast, genome sequencing of another subterranean animal, the naked mole ratHeterocephalus glaber, showed combined functional loss of more than a dozen key eye genes due to inactivating mutations[8]. The absence of obvious null mutations in essential eye genes despite dramatic effects on eye development suggests the possibility that Pachón cavefish might harbor cis-regulatory mutations in causing altered expression of eye genes and epigenetic regulators, and most likely the epigenetic regulation indirectly affecting the expression of large numbers of target eye genes at the same time. DNA methylation is one such epigenetic mechanism which is known to be able to simultaneously alter the expression of large cohorts of genes[9]. To test the possibility that altered DNA methylation plays a role in Pachón cave fish eye loss, we used CF and SF morphs of Astyanax mexicanus as well as wild type and DNA methylation and demethylation-deficient zebrafishDanio rerio to examine whether DNA methylation regulates eye formation, and whether eye loss in Pachón cave fish evolved at least in part through hypermethylation of key eye genes.
Results and Discussion
At 36 hpf Astyanax mexicanus CF and SF embryos are superficially indistinguishable with properly formed lenses and optic cups in both morphs (Fig. 1a,b). By five days of development, however, degeneration of eye tissue is clearly evident (Fig. 1c,d), and by adulthood CF eyes are completely absent (Fig. 1e,f)[10]. Eye regression is preceded by decreased expression of a number of different eye-specific genes, including the crystallins crybb1, crybb1c, and cryaa (Fig. 1g). The expression of large sets of genes can be repressed by DNA methylation based epigenetic silencing, as perhaps most famously shown for X chromosome inactivation[11]. New epigenetic DNA methyl “marks” are added by specific enzymes known as de novo DNA methyltransferases (DNMTs)[12], and we recently showed that one of these enzymes, dnmt3bb.1, is expressed in zebrafish hematopoietic stem and progenitor cells (HSPC) where its loss leads to failure to maintain HSPCs[13]. We found that dnmt3bb.1 is also expressed in the ciliary marginal zone (CMZ) of the developing eye, a specialized stem cell-containing tissue surrounding the lens that is responsible for generating neurons and other eye cell types[14-16] (Fig. 1h). In addition to their hematopoietic defects dnmt3bb.1 null mutant larvae and adults have enlarged eyes compared to their wild type (WT) siblings (Fig. 1i-k) with retinal hyperplasia (Supplementary Fig. 1), and increased expression of a number of different eye genes, including opn1lw1, gnb3a, and crx (Fig. 1l). Interestingly, the closely related Astyanax mexicanus dnmt3bb.1 gene, which also maps to an eye size QTL[6], shows 1.5-fold increased expression in Pachón CF compared to SF (Fig. 1m and Supplementary Fig. 2). The inverse correlation between eye size and dnmt3bb.1 expression in Danio rerio and Astyanax mexicanus led us to hypothesize that excessive Dnmt3bb.1-dependent methylation may globally repress expression of eye genes in CF.
Figure 1
Eye phenotypes in Astyanax mexicanus surface and cave fish, and in zebrafish Danio rerio wild type and dnmt3bb.1 mutant animals
a-d, Transmitted light photomicrographs of the heads of 36 hpf (a,b) and 5 dpf (c,d) surface (a,c) and cavefish (b,d) morphs of A. mexicanus. Black arrow mark the developing eyes in CF and SF. e,f, Photographic images of the heads of adult surface (e, with eyes) and cave (f, eyeless) morphs of A. mexicanus. g, Quantitative RT-PCR analysis of the percent relative expression of crybb1, crybb1c, cryaa, and myod in isolated heads from 54 hpf surface (orange columns) and cave (blue columns) morphs of A. mexicanus, normalized to surface fish levels. Histograms show mean, error bars represent s.e.m of three biological replicates; two-tailed t-test, *p<0.005. h, Whole mount in situ hybridization of a 36 hpf zebrafish eye probed for dnmt3bb.1, showing expression in the ciliary marginal zone (CMZ, arrows). i,j, Photographic images of the eyes of adult wild type sibling (i) and dnmt3bb.1 mutant (j) zebrafish. k, Quantitation of eye size in three week old wild type sibling and dnmt3bb.1 mutant animals. Histograms show mean, error bars represent s.d. in the relative eye size (n =18) two-tailed t-test, *p<0.05. l, Quantitative RT-PCR analysis of the percent relative expression of opn1lw1, gnb3a, and crx in adult wild type sibling (orange columns) and dnmt3bb.1 mutant (blue columns) zebrafish eyes, normalized to wild type sibling levels. Histograms show mean, error bars represent s.e.m of three biological replicates; two-tailed t-test, *p<0.005. m, Quantitative RT-PCR analysis of the percent relative expression of dnmt3bb.1 in surface and cave morphs of A. mexicanus, normalized to surface fish levels. All images are lateral views, rostral to the left. Histograms show mean, error bars represent s.e.m of three biological replicates, p<0.05 using t-test. Scale bars 100μM in b for a,b, 250μM in d for c,d, 3mm in e for e,h, 50μM for h and 1mm in j for i,j.
To more comprehensively examine whether increased DNA methylation correlates with reduced eye gene expression in CF versus SF, we performed combined RNAseq and whole genome bisulfite sequencing on RNA and DNA simultaneously co-isolated from 54 hpf CF or SF eyes, during a critical period for eye development in Pachón CF[10] (Fig. 2a). RNAseq analysis confirmed increased expression of dnmt3bb.1 in CF eyes (Fig. 2b,c). The RNAseq data also revealed that a large number of different eye development genes show reduced expression in CF eyes (Fig. 2c and Supplementary data 1). As in the naked mole rat, visual perception (GO:0007601) and electrophysiology of eye are the top down-regulated biological processes found using Gene Ontology (GO) (Fig. 2d) and Ingenuity Pathway Analysis (Supplementary Fig. 3), respectively. Ingenuity pathway analysis also predicted that the phototransduction pathway is the most affected signaling pathway in cavefish eyes compared to surface eyes (Supplementary Fig. 3).
Figure 2
Gene expression changes in cave versus surface fish morphs of Astyanax mexicanus
a, Diagram showing the workflow for obtaining larval eyes from A. mexicanus and for co-isolating eye DNA and RNA for whole genome assessment of DNA methylation and gene expression, respectively. b, Percent relative expression of dnmt3bb.1 in the eyes of A. mexicanus cave vs. surface fish morphs by comparison of their respective RNAseq data sets (2-replicates), normalized to surface fish levels, FPKM p<0.05. c, Log2 fold differential expression (p<0.05) of genes in A. mexicanus cave vs. surface fish morph RNAseq data sets, with down-regulated (red) or up-regulated (blue) expression of selected genes in CF noted. d, Listing of the Gene Ontology (GO) terms showing the greatest down-regulation in cave fish compared to surface fish. e-p, Assessment of opn1lw1(e-h), gnb3a (i-l), and crx (m-p) promoter DNA methylation (e,g,i,k,m,o) and gene expression (f,h,j,l,n,p) in 54 hpf surface (e,f,i,j,m,n) or cave (g,h,k,l,o,p) morphs of A. mexicanus. Panels show pie chart graphical representation of the percentage methylation of the promoter CpG (e,g,i,k,m,o), and representative whole mount in situ hybridization of the larval heads (f,h,j,l,n,p) using the probes noted (ventral views, rostral up, minimum 20-25 embryos were analyzed by in situ hybridization). Scale bar 100μM in p for f,h,j,l,n, and p.
Previous studies have shown that promoter methylation is highly correlated with gene repression[17]. One hundred and twenty-eight genes show substantially increased methylation within the 2 Kb of genomic DNA upstream from the transcriptional start site in CF versus SF (≥ 15% increase, p ≤ 0.05) and decreased expression in CF eyes compared to SF eyes (fold decrease ≤ 1.5, p ≤ 0.05) (Supplementary data 2). These include 39 and 26 genes annotated as having eye expression in mice and humans respectively (Supplementary data 3). Interestingly, nineteen of these genes have been previous linked to humaneye disorders (Table 1). These include opn1lw1, an opsin associated with cone-rod dystrophy and colorblindness[18,19], gnb3a, defective in autosomal recessive congenital stationary night blindness[20,21], and crx, a photoreceptor-specific transcription factor whose loss leads to blindness in humans[22,23]. Targeted bisulfite sequencing of DNA amplified from the opn1lw1, gnb3a, and crx promoter regions from 54 hpf SF or CF eyes confirms increased methylation of CpGs in the 5’ upstream sequences of each of these three genes (Fig. 2e,g,i,k,m,o, Supplementary Fig. 4). Whole mount in situ hybridization using opn1lw1, gnb3a, and crx probes also verifies strongly decreased expression of the three genes in CF versus SF eyes (Fig. 2f,h,j,l,n,p). Together, these data show that expression of key human eye disease-associated eye development genes is reduced in Pachón CF compared to their SF relatives, and that many of these eye genes also display increased promoter methylation. Interestingly, the crx transcription factor is itself necessary for proper expression of a large number of additional eye genes[23], many of which are also strongly reduced in CF eyes, even though most of these genes are not themselves methylated (Supplementary Fig. 5).
Table 1
Cavefish genes with significant promoter hypermethylation and reduced expression are associated with human eye disorders
Nineteen genes with both substantially increased methylation within the 2 Kb of genomic DNA upstream from the transcriptional start site (≥ 15% increase, p ≤ 0.05) and substantially decreased gene expression (fold decrease ≤ 1.5, p ≤ 0.05) in CF eyes compared to SF eyes that have also been linked to human eye disorders.
Eye Gene
Log2 Fold Change in Gene Expression
Change in Promoter Methylation (%)
Associated Human Eye Disease
STX3
-2.6545922
15.0532125
Microvillus inclusion disease
IMPG1
-2.0676398
15.7283333
Macular dystrophy
GNB3
-2.1535092
15.7549858
Congenital nigh blindness
RS1
-4.8162527
16.2271036
Retinoschisis
ELOVL4
-2.7387552
16.9231332
Stargard disease
TRPM1
-1.5194777
17.1153846
Congenital night blindness
KCNV2
-2.6133734
19.2768429
Retinal cone dystrophy
HEPACAM
-1.292728
19.2838136
Macrocephaly
CRX
-1.3492741
20.3620072
Retinitis pigmentosa
PDE6H
-2.4364817
20.8408953
Retinal cone dystrophy
PRPH2
-4.6162474
21.9236441
Retinitis pigmentosa
TMEM98
-1.3082467
23.6850216
Nanophthalmia
GRK1
-4.3915902
24.7866469
Oguchi disease
MYO7A
-1.342215
31.2060616
Usher syndrome
ATP6V0A1
-1.4653532
32.7039627
Macroautophagy
TDRD7
-1.8275097
34.9881388
Cataract
OPN1MW
-7.2622181
36.788428
Cone rod dystrophy
CRYGB
-4.1315449
39.2857143
Polar cataract
OPN1LW
-4.1525329
47.985771
Cone rod dystrophy
Increased expression of eye genes such as opn1lw1, gnb3a, and crx (Fig. 1l) and increased eye size (Fig. 1m) in dnmt3bb.1 mutant zebrafish is consistent with the hypothesis that DNA methylation represses eye gene expression to restrain or limit eye development. To experimentally test this idea, we examined whether increasing DNA methylation levels results in decreased eye gene expression and reduced eye development, using previously described zebrafish Ten-eleven translocation methylcytosine dioxygenase (TET) mutants that display global DNA hypermethylation[24]. Unlike DNMTs, which add methyl groups to cytosines to generate 5-methylcytosine, TET proteins oxidize methylcytosine to hydroxyl-methylcytosine, promoting DNA demethylation[25,26]. Like mammals, zebrafish have three TET enzymes with partially redundant functions, Tet1, Tet2, and Tet3. Tet2 and Tet3 are the main TET proteins responsible for converting methylcytosine into hydroxymethylcytosine; zebrafishtet1 triple mutants do not show additional phenotypes compared to tet2 double mutants[24]. We found that tet2 double mutants have smaller eyes than their wild type siblings (Fig. 3a-c). Targeted bisulfite sequencing and qRT-PCR on nucleic acids from whole eyes dissected from 48 hpf tet2 double mutants and their wild type siblings also revealed increased crx and gnb3a promoter methylation (Fig. 3d-g, Supplementary Fig. 6) and reduced crx and gnb3a gene expression (Fig. 3h) in the double mutants. Like dnmt3bb.1 mutants, tet2 double mutants also show hematopoietic defects. In addition, after 48 hpf tet2 double mutants begin to deteriorate with defects in brain development and do not survive beyond 5 dpf. These additional phenotypes may arise as a result of global DNA hypermethylation in these mutants.
Figure 3
Eye phenotype and associated gene expression changes in wild type and DNA methylation-deficient Danio rerio
a-b, Transmitted light photomicrographs of the heads of 48 hpf wild type sibling (a) and tet2 double mutant (b) embryos. c, Quantitation of eye size in 48 hpf wild type sibling and tet2 double mutant embryos. Histograms show mean, error bars represent s.d. in the relative eye size (n =10), two-tailed t-test, *p<0.05. d-g, Assessment of crx (d,f) and gnb3a (e,g), promoter DNA methylation in isolated eyes from 48 hpf wild type sibling (d,e) and tet2 double mutant (f,g) animals. h, Quantitative RT-PCR analysis of the percent relative expression of crx and gnb3a in isolated eyes from 48 hpf wild type sibling (orange columns) and tet2 double mutant (blue columns) animals. Histograms show mean, error bars represent s.e.m of three biological replicates; two-tailed t-test, *p<0.005. Scale bar 100μM in b for a and b.
To further test whether excess DNA methylation contributes to failure to maintain eye development in Pachón CF, we examined whether eye loss could be “rescued” by pharmacological inhibition of DNA methylation. 5-Azacytidine (Aza) is a well-characterized inhibitor of DNA methylation[27] approved for treatment of aberrant DNA methylation in myelodysplastic syndromepatients[28]. Since systemic administration of Aza to zebrafish embryos leads to severe pleiotropic defects and early lethality[29], we carried out single injections of either Aza or control DMSO carrier into the vitreous chamber of the left eye of 42-48 hpf CF embryos, and then scored phenotypes in both injected left and control right eyes at 5 days post fertilization (Fig. 4a). A single early injection of Aza into the left eye resulted in larger eyes than either the control uninjected right eyes in the same animals or the DMSO-injected left eyes of other animals (Fig. 4b). Histological analysis confirmed that Aza-injected 5 dpfCF eyes are significantly larger than uninjected or DMSO injected controls, and that they possess a more organized structure including morphologically well defined lens and retinal layers (Fig. 4c-e). Targeted promoter bisulfite sequencing of gnb3a from Aza-injected cavefish eyes revealed reduced DNA methylation at this locus (Supplementary Fig. 7A). Increased expression of gnb3a and crx was also noted in cavefish eyes injected with either Aza or the more “DNA specific” drug 5-aza-2-deoxycytidine (Aza-D) (Supplementary Fig. 7B), suggesting that either inhibiting the excess methylation of eye genes in cavefish results in increased expression of these genes and at least a partial “rescue” of eye development.
Figure 4
Partial rescue of cavefish eyes by AZA-mediated inhibition of eye DNA methylation
a, Schematic diagram showing the experimental procedure for injection of DMSO or AZA into 42-48 hpf cavefish embryo eyes. b, Quantitation of eye size in 5 dpf cavefish embryos injected in the left eye with DMSO or AZA. Histograms show mean, error bars represent s.d. in the relative eye size (18 DMSO and 12 Aza injected embryos) two-tailed t-test, *p<0.05. c-e, Histological analysis of H&E stained 5 dpf surface fish eye (c), DMSO injected cavefish eye (d) and AZA injected cavefish eye (e) (four to eight embryos per condition were sectioned and analyzed by H&E staining). f, Model depicting the role of DNA methylation in teleost eye development and degeneration. Hypermethylation and down-regulation of eye gene expression in cavefish and zebrafish tet double mutants leads to eye degeneration. Scale bar 100μM in a for a-c.
Together, our results suggest that DNA methylation plays a critical role in teleost eye development, and that increased DNA methylation-based eye gene repression is a major molecular mechanism underlying CF eye degeneration (Fig. 4f). Many of the key eye genes down-regulated in cave fish are conserved in humans and linked to eye disease and/or blindness, suggesting potential conserved function for these genes across evolution. Although a central role for DNA methylation in development and disease has been well-documented[30,31], our results suggest that small genetic changes that alter epigenetic regulation can play an important role in rapid adaptive evolution by triggering dramatic changes in the expression of large sets of genes. There is precedent for epigenetic changes resulting in dramatically altered developmental fates; for example, nutrition-driven changes in DNA methylation regulate the switch between queen and worker caste specification in honey bees (Apis mellifera)[32]. Our findings indicate that eye loss in Pachón cavefish occurs via distinct molecular mechanisms compared to naked mole rats, where inactivating mutations are found in multiple key eye genes. This could reflect differences in their evolutionary timescales. Cavefish evolved over the past one to five million years[1], while naked mole rats evolved seventy-three million years ago[8], allowing sufficient time to fix and select acquired mutations in genes essential for eye development. It remains to be seen whether altered epigenetic regulation has been used to generate phenotypic variability in other rapidly evolved animals.
Methods
Fish stocks and embryos
Zebrafish lines used in this study include dnmt3bb.1 (Ref. 13) and tet2 (Ref. 24) mutants and the EK wild type line. Surface and Pachon cave populations of Astyanax mexicanus are used in this study. Fish were spawned naturally and embryos were raised and staged as described previously[33,34]. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (12-039 and 18-016) of the National institute of child health and human development.
Genomic DNA isolation, bisulfite conversion, and sequencing
Surface and cavefish embryos were raised to described stages. Dechorionated embryos were transferred into 1X PBS without calcium and magnesium. Eyes were surgically removed using a pair of fine tip tungsten needles. Total cellular RNA and DNA was isolated from harvested eyes using ZR Duet DNA/RNA miniprep kit (Zymo Research). For whole genome bisulfite sequencing, 200 ng of purified genomic DNA was bisulfite converted using EZ DNA methylation-Lightning kit (Zymo research). Next Gen sequencing libraries were generated from the bisulfite converted DNA using TruSeq DNA methylation kit and TruSeq DNA methylation Index PCR primers (Illumina). Sequencing libraries of two biological replicates from surface and cavefish were run separately on two FlowCells of an Illumina HiSeq2500 sequencer operated in the RapidRun mode with V2 chemistry to yield about 400 million read pair reads (2 × 100bp) for each sample. Raw single-end sequence data was trimmed for quality and adapter sequence using Trimmomatic software, trimming leading or trailing bases at quality < 5 as well as using a sliding window requiring a 4 bp average of quality > 15. Reads trimmed below 50 bp were discarded. Following trimming, reads were aligned using Bismark software against a bisulfite converted Pachon cavefish genome using non-directional alignment. Using defined gene coordinates, gene body and promoter -2kb of TSS regions were assigned and combined conversions and non-conversions were summed to provide an overall bisulfite conversion rate per region. The ratio of conversions was then tested for change between conditions using a two-proportion z-test testing the hypothesis that the proportion of bisulfite conversion had altered between conditions. For targeted bisulfite analysis, bisulfite converted DNA was PCR amplified using primers designed by MethPrimer[35] (http://www.urogene.org/cgi-bin/methprimer/methprimer.cgi). One Taq Hotstart 2X master mix in standard buffer DNA polymerase (NEB) was used to amplify bisulfite converted DNA. PCR amplicons were purified and cloned using pCRII-TOPO TA cloning kit (Thermofisher). Miniprep plasmid DNA was sequenced using T7 or SP6 sequencing primers. Sequencing results were analyzed using QUMA[36] (http://quma.cdb.riken.jp/).
RNA isolation and sequencing
Total cellular RNA and DNA was isolated from the harvested eyes using ZR Duet DNA/RNA miniprep kit (Zymo Research). 300-900ng poly-A enriched RNA was converted to indexed sequencing libraries using the TruSeq Standard mRNA library prep kit (Illumina). Libraries for two biological replicates of surface and cavefish were combined and run on one FlowCell of an Illumina HiSeq 2500 sequencer in RapidRun mode with V2 chemistry. 100 million read pairs (2 × 100) per sample were sequenced. Paired-end reads were trimmed using trimmomatic and aligned to Pachon cavefish genome using RNA-STAR, quantitation performed with subread feature Counts and differential expression analysis performed with count data via DESeq2. Human, mouse and zebrafish homologs of cavefish genes were identified using Ensembl BioMart. Ingenuity pathway and Panther GO term enrichment analyses were carried out on RNA sequencing data to identify major signaling pathways and networks affected based on differentially expressed genes.
RNA isolation, cDNA synthesis and qRT-PCR
Total cellular RNA was isolated from harvested eyes and other tissues as mentioned in the text using ZR Duet DNA/RNA miniprep kit (Zymo Research). Equal amounts of RNA were converted into cDNA using the ThermoScript RT-PCR system (Invitrogen). Resulting cDNA was used in qPCR using SsoAdvanced™ Universal SYBR® Green Supermix (Biorad) on a CFX96 Real Time system. A minimum of three biological replicates were performed. Primers used in this study are listed in Supplementary Data 4.
Riboprobe synthesis, In situ hybridizations and histology
Antisense riboprobes were generated using Roche DIG and FITC labeling mix. Portions of the coding regions of genes were PCR amplified using One Taq Hotstart 2X master mix in standard buffer DNA polymerase (NEB) and cloned into pCRII-TOPO TA vector (Thermofisher). Sequence verified clones were used to generate antisense riboprobes using appropriate enzymes. The zebrafish dnmt3bb.1 probe was generated as described previously[13]. Whole mount in situ hybridization was carried out as described previously with a few modifications. To reduce non-specific hybridization and enhance signal to noise ratio we used 5% dextran sulfate (Sigma) in the hybridization buffer and pre-adsorbed anti-DIG and anti-FITC antibodies to whole cavefish powder. For histology, embryos and tissue samples were fixed using 4% para-formaldehyde overnight at 4°C and subsequently passed through ascending grades of alcohol followed by paraffin embedding. Sections were stained using hematoxylin and eosin (H&E).
Microinjection
Microinjection of 5-Azacytidine or 5-Aza-2’-deoxycytidine (Sigma) into Pachon cavefish embryonic eyes was carried out at 42-48 hpf embryos. Embryos were mounted laterally in low melting point agarose. Injection needles were pulled from filament-containing glass capillaries (World Precision Instruments Cat. No. TW100F-4) using a needle puller (Sutter Instruments). Needles were back loaded and a single 1-2 nl bolus of either 100μM 5-Azacytidine or 5-Aza-2’-deoxycytidine in 5% DMSO or 5% DMSO carrier alone was delivered into the vitreous of the left eye using a Pneumatic Picopump (World Precision Instruments). Embryos were removed from the agarose, allowed to continue to develop until 5 dpf, and then scored for eye size and/or used for histological analysis of the eyes. Injected embryos with axis or brain deformities were discarded from the analysis.
Eye size quantifications
For eye size measurements, embryos were imaged at same magnifications for mutants, treated and controls. All eye size measurements were performed by normalizing the area of the eyes to the head. Student’s t-test (paired) was performed on the normalized eye sizes.
Authors: Gavin Arno; Graham E Holder; Christina Chakarova; Susanne Kohl; Nikolas Pontikos; Alessia Fiorentino; Vincent Plagnol; Michael E Cheetham; Alison J Hardcastle; Andrew R Webster; Michel Michaelides Journal: JAMA Ophthalmol Date: 2016-08-01 Impact factor: 7.389
Authors: Suzanne E McGaugh; Joshua B Gross; Bronwen Aken; Maryline Blin; Richard Borowsky; Domitille Chalopin; Hélène Hinaux; William R Jeffery; Alex Keene; Li Ma; Patrick Minx; Daniel Murphy; Kelly E O'Quin; Sylvie Rétaux; Nicolas Rohner; Steve M J Searle; Bethany A Stahl; Cliff Tabin; Jean-Nicolas Volff; Masato Yoshizawa; Wesley C Warren Journal: Nat Commun Date: 2014-10-20 Impact factor: 14.919
Authors: Aniket V Gore; Brett Athans; James R Iben; Kristin Johnson; Valya Russanova; Daniel Castranova; Van N Pham; Matthew G Butler; Lisa Williams-Simons; James T Nichols; Erica Bresciani; Bejamin Feldman; Charles B Kimmel; Paul P Liu; Brant M Weinstein Journal: Elife Date: 2016-01-27 Impact factor: 8.140
Authors: Karen L Carleton; Daniel Escobar-Camacho; Sara M Stieb; Fabio Cortesi; N Justin Marshall Journal: J Exp Biol Date: 2020-04-23 Impact factor: 3.312
Authors: Suzanne E McGaugh; Johanna E Kowalko; Erik Duboué; Peter Lewis; Tamara A Franz-Odendaal; Nicolas Rohner; Joshua B Gross; Alex C Keene Journal: J Exp Zool B Mol Dev Evol Date: 2020-07-07 Impact factor: 2.656
Authors: Li Ma; Allen G Strickler; Amy Parkhurst; Masato Yoshizawa; Janet Shi; William R Jeffery Journal: Dev Biol Date: 2018-07-19 Impact factor: 3.582
Authors: Syed F Ahmad; Maryam Jehangir; Adauto L Cardoso; Ivan R Wolf; Vladimir P Margarido; Diogo C Cabral-de-Mello; Rachel O'Neill; Guilherme T Valente; Cesar Martins Journal: BMC Genomics Date: 2020-09-23 Impact factor: 3.969
Authors: Misty R Riddle; Ariel C Aspiras; Fleur Damen; John N Hutchinson; Daniel J-F Chinnapen; Julius Tabin; Clifford J Tabin Journal: J Exp Zool B Mol Dev Evol Date: 2020-06-02 Impact factor: 2.656